Related Experiment Video
Updated: Jan 20, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor
Tian Yang1, Ya-Long Feng1, Lin Chen1
1Faculty of Life Science & Medicine, Northwest University, Xi'an, China.
Abstract:
The role of aryl hydrocarbon receptor (AhR) as a ligand-activated transcription factor in the field of cancer has gradually been unveiled. A strong body of evidence indicated that AhR is implicated in cell proliferation and apoptosis, immune metabolism and other processes, which further affected tumor growth, survival, migration, and invasion. Therefore, AhR targeted therapy may become a new method for cancer treatment and provide a new direction for clinical tumor treatment. Astonishingly, the largest source of exposure of animals and humans to AhR ligands (synthetic and natural) comes from the diet. Myriad studies have described that various natural dietary chemicals can directly activate and/or inhibit the AhR signaling pathway. Of note, numerous natural products contribute to AhR active, of which dietary flavonoids are the largest class of natural AhR ligands. As interest in AhR and its ligands increases, it seems sensible to summarize current research on these ligands. In this review, we highlight the role of AhR in tumorigenesis and focus on the double effect of AhR in cancer therapy. We explored the molecular mechanism of AhR ligands on cancer through a few AhR agonists/antagonists currently in clinical practice. Ultimately, we summarize and highlight the latest progression of dietary flavonoids as AhR ligands in cancer inhibition, including the limitations and deficiencies of it in clinical research. This review will offer a comprehensive understanding of AhR and its dietary ligands which may dramatically pave the way for targeted cancer treatment.
Insights
Dietary flavonoids activate the aryl hydrocarbon receptor (AhR), influencing cancer. This review explores AhR
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor increasingly recognized for its role in cancer.
- AhR signaling influences critical cellular processes such as proliferation, apoptosis, and immune metabolism, impacting tumor progression.
- Dietary compounds, particularly flavonoids, are significant natural sources of AhR ligands.
Purpose of the Study:
- To review the dual role of AhR in cancer therapy.
- To explore the molecular mechanisms of AhR ligands in cancer.
- To summarize the potential of dietary flavonoids as AhR ligands for cancer inhibition.
Main Methods:
- Literature review focusing on AhR's role in tumorigenesis.
- Analysis of molecular mechanisms of AhR agonists/antagonists in cancer.
- Examination of dietary flavonoids as natural AhR ligands.
Main Results:
- AhR plays a complex, often dual, role in cancer development and treatment.
- Dietary flavonoids represent a major class of natural AhR ligands with potential anti-cancer effects.
- Understanding AhR ligand mechanisms offers new therapeutic avenues.
Conclusions:
- AhR targeted therapy holds promise for novel cancer treatments.
- Dietary flavonoids are promising candidates for AhR-mediated cancer inhibition.
- Further clinical research is needed to address limitations of dietary flavonoids in cancer therapy.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nomenclature of Aryl and Heterocyclic Amines
Nature and Nurture
Dietary Connections
What is Natural Selection?
Internal Receptors

